Real-time enrollment status for this peripheral neuropathy due to chemotherapy clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 12:58 PM UTC
| NCT Number | NCT06744816 |
| Recruiting Status | Recruiting |
| Condition | Peripheral Neuropathy Due to Chemotherapy |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | June 26, 2026 (Jun 26, 2026) |
As of September 1, 2026: Clinical trial NCT06744816 is currently recruiting participants. This early_phase1 study for peripheral neuropathy due to chemotherapy is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06744816 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06744816 was last updated Jun 26, 2026 (June 26, 2026). HelloStudys verifies this status automatically.